Received Jun 2, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | Y7XG3 | IM / LA |
he developed an itchy rash on both of his forearms; few dots on his back and back of his calves, but they are not itchy; This non-serious case was reported by a consumer via call center representative and described the occurrence of itchy rash in a 60-year-old male patient who received Herpes zoster (Shingrix) (batch number Y7XG3, expiry date 27-MAR-2027) for prophylaxis. On 12-MAY-2025, the patient received the 1st dose of Shingrix (left deltoid) .5 ml. On 19-MAY-2025, 7 days after receiving Shingrix, the patient experienced itchy rash (Verbatim: he developed an itchy rash on both of his forearms) and rash (Verbatim: few dots on his back and back of his calves, but they are not itchy). The outcome of the itchy rash and rash were not resolved. It was unknown if the reporter considered the itchy rash and rash to be related to Shingrix. It was unknown if the company considered the itchy rash and rash to be related to Shingrix. Additional Information: GSK Receipt Date :27-MAY-2025 Reporter reported that patient received his first Shingrix vaccine in the left arm on 12th May 2025. He reported 1 week later on 19th May 2025 he developed an itchy rash on both of his forearms, and it was still ongoing. Reporter also reported a few dots on his back and back of his calves, but they were not itchy. Reporter stated his wife had a prescription medication (unknown name) for itching that he put on the itchy rash a couple times.